Vitamin D Deficiency and Its Association with Cirrhosis among Patients with Chronic Hepatitis C Infection
Vitamin D Deficiency and Association with Chronic Hepatitis C Infection
DOI:
https://doi.org/10.54393/pjhs.v7i3.3816Keywords:
Vitamin D Deficiency, Chronic Hepatitis C, Cirrhosis, Liver Dysfunction, Hepatic BiomarkersAbstract
Vitamin D deficiency represents a common metabolic disturbance in chronic liver disorders, with a particularly high prevalence among individuals affected by chronic hepatitis C virus (HCV) infection. Evidence reported that progressive hepatic dysfunction can be linked to the waning levels of vitamin D; the information on South Asian populations is scarce. Objectives: To evaluate the association between deficient serum vitamin D levels and the presence of liver cirrhosis among individuals with HCV infection. Methods: The case-control study involved 162 chronic hepatitis C patients in the Department of Medicine, Kishwar Fazal Teaching Hospital, Lahore. Demographic, clinical, and laboratory parameters were taken. The level of vitamin D in serum was determined and categorized based on the severity. The statistical analysis was conducted using SPSS version 25.0 through suitable tests. Results: The study population had a vitamin D deficiency of 92.0%. Cases of severe vitamin D deficiency were found 30.2 higher in cirrhotic patients than in non-cirrhotic patients (30.2% vs. 14.0%). Severe vitamin D deficiency, female gender, and longer HCV infection were significantly related to cirrhosis. Extremely vitamin-D-deficient patients showed a high concentration of alanine aminotransferase and aspartate aminotransferase, elevated serum bilirubin, and decreased serum albumin, which is indicative of severe hepatic dysfunction. Conclusions: In chronic hepatitis C patients, vitamin D deficiency, especially the severe form, is highly correlated with cirrhosis and poor biochemical markers in the patients. These results justify the inclusion of regular screening of vitamin D status in the overall evaluation of patients with chronic HCV infection.
References
Tergast TL, Blach S, Tacke F, Berg T, Cornberg M, Kautz A et al. Updated Epidemiology of Hepatitis C Virus Infections and Implications for Hepatitis C Virus Elimination in Germany. Journal of Viral Hepatitis. 2022 Jul; 29(7): 536-42. doi: 10.1111/jvh.13680. DOI: https://doi.org/10.1111/jvh.13680
Stasi C, Milli C, Voller F, Silvestri C. The Epidemiology of Chronic Hepatitis C: Where We Are Now. Livers. 2024 Mar; 4(2): 172-81. doi: 10.3390/livers4020013. DOI: https://doi.org/10.3390/livers4020013
Reuter TQ, Gomes-Gouvea M, Chuffi S, Duque UH, Carvalho JA, Perini W et al. Hepatitis B Virus Genotypes and Subgenotypes and the Natural History and Epidemiology of Hepatitis B. Annals of Hepatology. 2022 Jan; 27: 100574. doi: 10.1016/j.aohep.2021.100574. DOI: https://doi.org/10.1016/j.aohep.2021.100574
Kenfack-Momo R, Kenmoe S, Takuissu GR, Ebogo-Belobo JT, Kengne-Nde C, Mbaga DS et al. Epidemiology of Hepatitis B Virus and/or Hepatitis C Virus Infections among People Living with Human Immunodeficiency Virus in Africa: A Systematic Review and Meta-Analysis. PloS One. 2022 May; 17(5): e0269250. doi: 10.1371/journal.pone.0269250. DOI: https://doi.org/10.1371/journal.pone.0269250
Udomsinprasert W and Jittikoon J. Vitamin D and Liver Fibrosis: Molecular Mechanisms and Clinical Studies. Biomedicine and Pharmacotherapy. 2019 Jan; 109: 1351-60. doi: 10.1016/j.biopha.2018.10.140. DOI: https://doi.org/10.1016/j.biopha.2018.10.140
Arai T, Atsukawa M, Tsubota A, Koeda M, Yoshida Y, Okubo T et al. Association of Vitamin D Levels and Vitamin D-Related Gene Polymorphisms with Liver Fibrosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease. Digestive and Liver Disease. 2019 Jul; 51(7): 1036-42. doi: 10.1016/j.dld.2018.12.022. DOI: https://doi.org/10.1016/j.dld.2018.12.022
Okubo T, Atsukawa M, Tsubota A, Ono H, Kawano T, Yoshida Y et al. Effect of Vitamin D Supplementation on Skeletal Muscle Volume and Strength in Patients with Decompensated Liver Cirrhosis Undergoing Branched Chain Amino Acids Supplementation: A Prospective, Randomized, Controlled Pilot Trial. Nutrients. 2021 May; 13(6): 1874. doi: 10.3390/nu13061874. DOI: https://doi.org/10.3390/nu13061874
Yodoshi T, Orkin S, Arce-Clachar AC, Bramlage K, Liu C, Fei L, El-Khider F et al. Vitamin D Deficiency: Prevalence and Association with Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease. European Journal of Clinical Nutrition. 2020 Mar; 74(3): 427-35. doi: 10.1038/s41430-019-0493-y. DOI: https://doi.org/10.1038/s41430-019-0493-y
Huang CZ, Zhang J, Zhang L, Yu CH, Mo Y, Mo LY. Serum Vitamin D And Vitamin-D-Binding Protein Levels in Children with Chronic Hepatitis B. World Journal of Gastroenterology. 2021 Jan; 27(3): 255. doi: 10.3748/wjg.v27.i3.255. DOI: https://doi.org/10.3748/wjg.v27.i3.255
Pop TL, Sîrbe C, Benţa G, Mititelu A, Grama A. The Role of Vitamin D and Vitamin D Binding Protein in Chronic Liver Diseases. International Journal of Molecular Sciences. 2022 Sep; 23(18): 10705. doi: 10.3390/ijms231810705. DOI: https://doi.org/10.3390/ijms231810705
Ebadi M, Bhanji RA, Mazurak VC, Lytvyak E, Mason A, Czaja AJ et al. Severe Vitamin D Deficiency Is a Prognostic Biomarker in Autoimmune Hepatitis. Alimentary Pharmacology and Therapeutics. 2019 Jan; 49(2): 173-82. doi: 10.1111/apt.15029. DOI: https://doi.org/10.1111/apt.15029
Ramadan HK, Makhlouf NA, Mahmoud AA, Abd Elrhman M, El-Masry MA. Role of Vitamin D Deficiency as a Risk Factor for Infections in Cirrhotic Patients. Clinics and Research in Hepatology and Gastroenterology. 2019 Feb; 43(1): 51-7. doi: 10.1016/j.clinre.2018.09.001. DOI: https://doi.org/10.1016/j.clinre.2018.09.001
Lin S, Wang W, Shi L, Yang X, Chen Y, Liu X et al. Severe Vitamin D Deficiency Is Strongly Associated with Liver Dysfunction and Disease Severity in Hepatitis B Virus-Related Cirrhosis and Liver Failure Patients. Journal of Nutritional Science and Vitaminology. 2022 Feb; 68(1): 16-22. doi: 10.3177/jnsv.68.16. DOI: https://doi.org/10.3177/jnsv.68.16
Barchetta I, Cimini FA, Cavallo MG. Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update. Nutrients. 2020 Oct; 12(11): 3302. doi: 10.3390/nu12113302. DOI: https://doi.org/10.3390/nu12113302
Rezaei S, Tabrizi R, Nowrouzi-Sohrabi P, Jalali M, Shabani-Borujeni M, Modaresi S et al. The Effects of Vitamin D Supplementation on Anthropometric and Biochemical Indices in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology. 2021 Nov; 12: 732496. doi: 10.3389/fphar.2021.732496. DOI: https://doi.org/10.3389/fphar.2021.732496
Triantos C, Aggeletopoulou I, Thomopoulos K, Mouzaki A. Vitamin D—Liver Disease Association: Biological Basis and Mechanisms of Action. Hepatology. 2021 Aug; 74(2): 1065-73. doi: 10.1002/hep.31699. DOI: https://doi.org/10.1002/hep.31699
Mansour-Ghanaei F, Pourmasoumi M, Hadi A, Ramezani-Jolfaie N, Joukar F. The Efficacy of Vitamin D Supplementation Against Nonalcoholic Fatty Liver Disease: A Meta-Analysis. Journal of Dietary Supplements. 2020 Jul; 17(4): 467-85. doi: 10.1080/19390211.2019.1624671. DOI: https://doi.org/10.1080/19390211.2019.1624671
Wei Y, Wang S, Meng Y, Yu Q, Wang Q, Xu H et al. Effects of Vitamin D Supplementation in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. International Journal of Endocrinology and Metabolism. 2020 Jul; 18(3): e97205. doi: 10.5812/ijem.97205. DOI: https://doi.org/10.5812/ijem.97205
Czaja AJ and Montano-Loza AJ. Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis. Digestive Diseases and Sciences. 2019 Feb; 64(2): 324-44. doi: 10.1007/s10620-018-5351-6. DOI: https://doi.org/10.1007/s10620-018-5351-6
Liu S, Liu Y, Wan BO, Zhang H, Wu S, Zhu Z et al. Association between Vitamin D Status and Non-Alcoholic Fatty Liver Disease: A Population-Based Study. Journal Of Nutritional Science and Vitaminology. 2019 Aug; 65(4): 303-8. doi: 10.3177/jnsv.65.303. DOI: https://doi.org/10.3177/jnsv.65.303
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Pakistan Journal of Health Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments



